🚀 Karman Space & Defense (KRMN): $1.03M Insider Buying, $1.3B Backlog & 58% Revenue Growth

🚀 KRMN Stock Analysis: Three Directors Buy the 70% Post-IPO Plunge Near $37 🛰️💥

Record Q2 Growth Meets a 44x Forward P/E, 13% Short Interest and Negative Momentum — FUNStock Index: 7.95/10

Karman Space & Defense

NYSE: KRMN
$35.75
+$0.50 (+1.42%)
As of Sep. 18, 2026, 4:10 PM ET

🛰️ What Exactly Does Karman Do?

Karman designs and manufactures mission-critical systems for defense and space applications, including payload and protection systems, aerodynamic interstage systems and propulsion and launch systems. Its products support missile defense, hypersonics, tactical weapons, submarines and space-launch programs.

In other words, Karman doesn't build the whole rocket. It makes some of the stuff you'd really prefer not to fail once the rocket leaves Earth.

And business is booming.

🕵️ Trigger #1: Three Directors Suddenly Start Buying

On September 16, three Karman directors purchased stock:

David Stinnett: 27,000 shares at a weighted-average $37.32, worth approximately $1.008 million. The SEC filing confirms Stinnett's shares were acquired in multiple transactions between $36.99 and $37.52.

Mary Petryszyn: 500 shares at $37.44, worth $18,720.

Stephen Twitty: 275 shares at $36.79, worth $10,117.

Combined: approximately $1.036 million.

That's notable because it represents the first insider purchasing cluster since Karman's February 2025 IPO.

But don't launch the champagne rocket yet. 🍾🚀

Karman insiders previously sold substantial amounts of stock at much higher prices following the IPO. The historical selling therefore dilutes—but does not erase—the significance of today's buying.

And there's another nuance: roughly 97% of this new cluster's dollar value came from Stinnett alone. Three directors bought, but economically this is principally a $1 million Stinnett conviction signal.

✅ FUNanc1al Atomic Statement #1

“An insider cluster becomes more interesting when the stock collapses before the insiders arrive: at Karman, three directors buying near $37 after a roughly 70% drawdown doesn't prove a bottom—but it tells investors exactly where the boardroom finally found the price interesting.” — FUNanc1al

🏛️ Trigger #2: Institutions Are Practically Sitting on Each Other

Reported institutional ownership stands above 100% of shares outstanding, with major holders including FMR, BlackRock and State Street. The apparent >100% figure should not be interpreted literally as institutions owning more economic shares than exist; reporting dates, share lending, duplicate classifications and changing share counts can distort aggregated ownership statistics.

The real takeaway is simpler:

Institutional participation is enormous.

Meanwhile, short interest stood around 13.1%, with roughly 14.3 million shares short and more than four days to cover according to the dataset used for this analysis. That's meaningful bearish positioning—but I'd call it squeeze potential, not a squeeze waiting to happen.

Shorts need a catalyst to run for the exits. Fortunately for bulls, Karman has a few candidates.

For Karman Space & Defense (KRMN)'s institutional ownership breakdown, 🔍 see here.

📈 Trigger #3: Wall Street Likes the Story

Recent analyst data show a broadly bullish consensus, including Guggenheim's recent initiation at Buy with a $63 target.

That's useful context, but price targets aren't intrinsic value delivered by FedEx. 📦

KRMN has already demonstrated how violently expectations can change: a stock that traded above $118 in January now changes hands below $36.

Which brings us to the problem.

💰 Trigger #4: Houston, We Still Have a Valuation

At $35.75, Karman is dramatically cheaper than it was.

It is not cheap.

The supplied valuation snapshot puts KRMN around:

Trailing P/E: 130.6x
Forward P/E: 44.1x
Price/Sales: 7.9x
Price/Book: 11.1x
EV/EBITDA: 34.8x

Those aren't bargain-bin multiples.

But here's where the story gets interesting: the valuation has compressed dramatically while the underlying business has continued expanding.

A 44x forward earnings multiple can become much less frightening if earnings keep growing rapidly. It can also become extremely frightening if growth disappoints.

That's growth-stock investing in one sentence. 😬

✅ FUNanc1al Atomic Statement #2

“A stock falling 70% doesn't automatically become cheap: when Karman still trades near 44 times forward earnings after the collapse, the investment case depends less on how far the price has fallen than on how quickly the business can grow into the valuation.” — FUNanc1al

🔥 Trigger #5: Then You See the Earnings

This is where the bull case earns credibility.

Karman's Q2 2026 revenue reached a record $182.1 million, up 58.2% year over year, including 24.4% organic growth. Net income jumped 106.1% to $14 million, while adjusted EBITDA rose 54.7% to $54.6 million.

Backlog reached a record $1.3 billion, up 65% from year-end 2025, while quarterly bookings approached $500 million. Management raised full-year revenue guidance to $730–$745 million and adjusted EBITDA guidance to $215–$222.5 million.

Now the valuation starts making more sense.

Not cheap.

But no longer inexplicable.

💸 Cash Flow, Debt & the CFO Question

Free cash flow deserves monitoring. Karman has been investing aggressively in capacity and acquisitions, and recent figures show negative FCF through H1 2026.

Debt deserves monitoring too.

But there are offsets: Karman completed a debt repricing expected to save approximately $4 million annually in interest expense, while its rapidly expanding EBITDA should help the leverage equation if execution continues.

And the CFO departure shouldn't automatically be treated as a red flag. Karman announced it as a planned succession, with Chris Boynton becoming CFO on September 14 and Mike Willis remaining through a phased transition before departing by year-end.

👉 Want the full picture? Dive into Karman Space & Defense (KRMN)'s financials here.

🎭 The FUNanc1al View

Here's what makes KRMN fascinating:

🐂 The bulls have a point: revenue +58%, net income +106%, backlog $1.3 billion, guidance raised, huge institutional participation and directors finally buying.

🐻 The bears have a point: the valuation remains rich, leverage matters, free cash flow needs improvement, short interest is elevated and price momentum remains ugly.

Sometimes both sides are right.

The argument is simply about price.

📌 Signal Extract

“An insider cluster becomes more interesting when the stock collapses before the insiders arrive: at Karman, three directors buying near $37 after a roughly 70% drawdown doesn't prove a bottom—but it tells investors exactly where the boardroom finally found the price interesting.” — FUNanc1al

🎯 High-Conviction Takeaway

“A stock falling 70% doesn't automatically become cheap: when Karman still trades near 44 times forward earnings after the collapse, the investment case depends less on how far the price has fallen than on how quickly the business can grow into the valuation.” — FUNanc1al

⚡ Quick Take / TL;DR

FUNStock Index: 7.95 / 10

Karman is one of those frustrating stocks where it's easier to love the business than the price.

The operating trajectory is impressive. The backlog is enormous. Directors have finally started buying. Defense and space demand provide powerful tailwinds.

But a 44x forward P/E and ~35x EV/EBITDA still demand execution, while leverage, negative momentum, short interest and KRMN's very short history as a public company add risk.

Our stance: compelling growth story, imperfect entry price. For investors already interested in KRMN, staged accumulation rather than an all-at-once bet is one way to manage the volatility risk.

🚀 Great rocket. We're just not convinced the ticket is cheap yet.

FUNStock Index: 7.95 / 10.

❓ FAQ

Why are Karman directors buying KRMN stock?
Three directors bought roughly $1.04 million around $37 on September 16. The filings disclose the purchases, not their motives, so the safest interpretation is that they constitute a positive alignment signal—not proof the stock has bottomed.

Is KRMN cheap after falling roughly 70%?
Cheaper, absolutely. Cheap, not obviously. At roughly 44x forward earnings and 35x EV/EBITDA in a recent valuation snapshot, substantial future growth remains embedded in the price.

What's the strongest fundamental argument for KRMN?
Growth plus visibility: Q2 revenue rose 58.2%, organic growth was 24.4%, and backlog reached $1.3 billion, a record. 

What's the biggest risk?
Expectations. High-growth stocks carrying premium multiples can fall sharply if growth, margins, cash flow or contract timing disappoint.

💡💡💡 Curious about another deep oil exploration play? (joke)
Check our takes on UnitedHealth Group or even Oscar Health.

🧠 Food for Thought: The Cross-Hub Connection

Karman offers a useful lesson extending beyond aerospace and defense:

A great company and a great stock are not always the same thing—because price sits between the two.

The psychology gets particularly dangerous after a 70% decline. Our brains instinctively anchor to $118 and see $36 as “cheap.”

But markets don't owe stocks a return trip to their old highs.

Forget where KRMN traded.

Ask what the business is worth now.

That's investing. The rocket emojis are optional. 🚀

👤 About the Author

Frédéric Marsanne is the founder of FUNanc1al—part market analyst, part storyteller, part accidental comedian. A longtime investor, entrepreneur, and venture-builder across tech, biotech, and fintech, he now blends rigorous financial analysis with a twist of humor to help readers laugh, learn, live healthier lives, and invest a little wiser.

His research focuses on insider buying, hedge funds, valuation, behavioral finance, long-term wealth creation, and the fascinating intersections between business, science, technology, health, passions, and everyday life.

When not decoding SEC filings or poking fun at earnings calls, he's building Cl1Q, writing fiction, painting, creating videos, or discovering new passions to FUNalize.

📝 Editorial Note

This analysis reflects information available through September 18, 2026 and is intended as a snapshot of the investment thesis at publication. Market prices, analyst estimates, insider ownership, institutional holdings, short interest, financial results, valuation multiples, and company guidance can change rapidly. FUNanc1al emphasizes primary-source financial analysis where practicable and distinguishes reported facts from our own interpretation and investment thesis.

Every FUNanc1al article is grounded in human research, analysis, and editorial judgment. Modern AI tools may assist with research organization, editing, and presentation, but every opinion, conclusion, rating, and editorial judgment remains subject to human oversight and responsibility.

To learn more about how we research, write, and review every article, please visit our Editorial Process page.

At FUNanc1al, we focus on high-conviction ideas supported by multiple independent signals—not just headlines.

No single indicator guarantees investment success.

But when insider buying, strong cash generation, institutional sponsorship, the prospect of improving fundamentals, and attractive valuations begin aligning...

we believe those opportunities deserve a closer look.

FUNanc1al combines company filings, earnings materials, insider transaction data, institutional ownership information, valuation metrics, market behavior, and independent analysis to identify signals that may matter to long-term investors.